Literature DB >> 9027427

The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm.

C R Wilkinson1, L M Bower, C Warren.   

Abstract

Serum hyaluronidase activity (HAE) and hyaluronic acid (HA) concentration were measured in sera from patients with disseminated neoplasm and compared to those of normal controls. The serum HAE activity in disseminated neoplasm (mean, 12.6 mumol N-acetylglucosamine (NAG)/min/1; range, 5.2-24.7 mumol NAG/min/1) was significantly lower (t = 6.7, p < 0.001) than in normal controls (mean, 17.1 mumol NAG/min/1; range, 11.5-27.0 mumol NAG/min/1). The serum HA concentration in patients with disseminated neoplasm (mean, 8199.7 micrograms/l; range, 42.0-496,000 micrograms/l) was significantly higher (t = 2.63, 0.01 > p> 0.001) than in normal age-matched controls (mean, 55.6 micrograms/l; range, 10.0-348.0 micrograms/l). A negative correlation was found between the serum HAE activity and the HA concentration (r = -0.45, t = 5.92, p < 0.001). The possible reasons for the low serum HAE activity and the raised serum HA concentration in patients with disseminated neoplasm and the negative correlation between the results are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9027427     DOI: 10.1016/s0009-8981(96)06421-2

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Serum hyaluronic acid levels in patients with ankylosing spondylitis.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Lale Cerrahoglu; Banu Isbilen
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

2.  In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.

Authors:  A Luquita; L Urli; M J Svetaz; A M Gennaro; M E Giorgetti; G Pistone; R Volpintesta; S Palatnik; M Rasia
Journal:  J Biomed Sci       Date:  2010-02-12       Impact factor: 8.410

3.  Serum hyaluronan levels in patients with knee osteoarthritis.

Authors:  Yasemin Turan; Serpil Bal; Alev Gurgan; Hatice Topac; Mehmet Koseoglu
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.